Overview

Update
Total Equity Funding
$10M in 1 Round from 1 Investor
Most Recent Funding
$10M Series A on December 16, 2011
Headquarters:
San Carlos, CA
Description:
Signature Therapeutics is focused on creating novel medicines to improve upon the therapeutic utility of existing drugs.
Categories:
Biotechnology
Website:
http://www.signaturerx.com/view.cfm/20/Signature-Therapeutics
Social:

Company Details

Update

Signature Therapeutics, Inc. (formerly PharmacoFore) is a privately-held biopharmaceutical company focused on creating novel medicines to improve upon the therapeutic utility of existing drugs, enhance patient care, and prevent the misuse, abuse, and overdose of prescription medications. They have developed a resilient business model for creating long-term value by pursuing a portfolio of carefully chosen programs where in drug activity is based upon known mechanisms-of-action and where human proof-of-concept can be achieved early in clinical trials. Their initial focus is on medicines for the central nervous system (CNS).

Funding Rounds (1) - $10M

Update
DateAmount / RoundValuationLead InvestorInvestors
Dec, 2011$10M / Series A1

Investors (1)

InvestorRound(s)Partner(s)
Series A (Lead)-

Current Team (3)

Update

News (1)

Update
DateNews
Dec 19, 2011OnBioVC - PharmacoFore, Inc.: Series A $10MbyOnBioVC

Offices/Locations (1)

Update
  • Office

    75 Shoreway Rd, Suite D

    San Carlos, CA 94070

    USA

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos